Pulmonary outcome in juvenile dermatomyositis: A case-control study

Annals of the Rheumatic Diseases

Volumn 70, Issue 1, 2011, Pages 86-91

  Sanner, Helga ^a,b   Aaløkken, Trond Mogens ^b   Gran, Jan Tore ^a,b   Sjaastad, Ivar ^a,c   Johansen, Bjørn ^a,b   Flatø, Berit ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADOLESCENT; ADULT; ARTICLE; BODY PLETHYSMOGRAPHY; CALCINOSIS; CHEST WALL CALCINOSIS; CHILD; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; FOLLOW UP; HEALTH STATISTICS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SPIROMETRY; SYSTEMIC DISEASE; TOTAL LUNG CAPACITY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; MALE; PROGNOSIS; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; YOUNG ADULT;

EID: 78650634871     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.131433     Document Type: Article

References (36)

1. Fathi M, Lundberg IE, Tornling G. Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med 2007; 28 : 451-8 .
2. Trapani S, Camiciottoli G, Vierucci A, et al. Pulmonary involvement in juvenile dermatomyositis: a two-year longitudinal study. Rheumatology (Oxford) 2001; 40 : 216-20 .
3. Kobayashi I, Yamada M, Takahashi Y, et al. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. Rheumatology (Oxford) 2003; 42 : 371-4 .
4. Tosun A, Serdaroglu G, Aslan MT, et al. Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement. Rheumatol Int 2006; 26 : 1040-3 .
5. Prahalad S, Bohnsack JF, Maloney CG, et al. Fatal acute fi brinous and organizing pneumonia in a child with juvenile dermatomyositis. J Pediatr 2005; 146 : 289-92 .
6. Pachman LM, Cooke N. Juvenile dermatomyositis: a clinical and immunologic study. J Pediatr 1980; 96 : 226-34
7. Chiu SK, Yang YH, Wang LC, et al. Ten-year experience of juvenile dermatomyositis: a retrospective study. J Microbiol Immunol Infect 2007; 40 : 68-73 .
8. Morinishi Y, Oh-Ishi T, Kabuki T, et al. Juvenile dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease. Mod Rheumatol 2007; 17 : 413-17 .
9. Constantin T, Ponyi A, Orbán I, et al. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary - clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Autoimmunity 2006; 39 : 223-32 .
10. Blane CE, White SJ, Braunstein EM, et al. Patterns of calcifi cation in childhood dermatomyositis. AJR Am J Roentgenol 1984; 142 : 397-400 .
11. Woo P. Theoretical and practical basis for early aggressive therapy in paediatric autoimmune disorders. Curr Opin Rheumatol 2009; 21 : 552-7 .
12. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26 : 948-68 .
13. Padley SP, Hansell DM, Flower CD, et al. Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infi ltrative lung disease. Clin Radiol 1991; 44 : 222-6 .
14. Bohan A, Peter JB. Polymyositis and dermatomyositis (fi rst of two parts). N Engl J Med 1975; 292 : 344-7 .
15. Sanner H, Gran JT, Sjaastad I, et al. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford) 2009; 48 : 1541-7 .
16. Sanner H, Kirkhus E, Merckoll E, et al. Long term muscular outcome, predisposing and prognostic factors in Juvenile Dermatomyositis: a case control study. Arthritis Care Res (Hoboken) 2010 ;62:1103-11.
17. Bode RK, Klein-Gitelman MS, Miller ML, et al. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003; 49 : 7-15 .
18. Isenberg DA, Allen E, Farewell V, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004; 43 : 49-54 .
19. Alexanderson H, Lundberg IE, Stenström CH. Development of the myositis activities profi le - validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis. J Rheumatol 2002; 29 : 2386-92 .
20. Feldman BM, Ayling-Campos A, Luy L, et al. Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. J Rheumatol 1995; 22 : 326-31 .
21. S ultan S M, I oannou Y, Moss K, e t al. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 2002; 41 : 22-6 .
22. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26 : 319-38 .
23. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26 : 720-35 .
24. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26 : 511-22 .
25. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory fl ows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Offi cial Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16 : 5-40 .
26. Cotes JE, Chinn DJ, Quanjer PH, et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Offi cial Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16 : 41-52 .
27. Austin JH, Müller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996; 200 : 327-31 .
28. F eldman B M, Rider LG, Reed AM, e t al. J uvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008; 371 : 2201-12 .
29. Fathi M, Dastmalchi M, Rasmussen E, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004; 63 : 297-301 . (Pubitemid 38250674)
30. Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med 2007; 28 : 369-78 .
31. Fathi M, Vikgren J, Boijsen M, et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 2008; 59 : 677-85 .
32. Webb W, Muller N, Naidich DP. High-resolution CT of the lung. Philadelphia, Pennsylvania, USA: Lipincott Williams & Wikins, 2009 .
33. Lilleby V, Aaløkken TM, Johansen B, et al. Pulmonary involvement in patients with childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol 2006; 24 : 203-8 .
34. Kanengiser LC, Rapoport DM, Epstein H, et al. Volume adjustment of mechanics and diffusion in interstitial lung disease. Lack of clinical relevance. Chest 1989; 96 : 1036-42 .
35. Sandler M. Is the lung a 'target organ' in diabetes mellitus? Arch Intern Med 1990; 150 : 1385-8 .
36. Steen VD, Graham G, Conte C, et al. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992; 35 : 765-70 .